Cargando…
Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective
Coronavirus disease 2019 (COVID-19), which is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared by the World Health Organization (WHO) as a global pandemic on March 11, 2020. SARS-CoV-2 targets the respiratory system, resulting in symptoms such as fever,...
Autores principales: | Alnefaie, Alaa, Albogami, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462599/ https://www.ncbi.nlm.nih.gov/pubmed/32905015 http://dx.doi.org/10.1016/j.jsps.2020.08.024 |
Ejemplares similares
-
Effects of neoadjuvant therapies on genetic regulation of targeted pathways in ER+ primary ductal breast carcinoma: A meta-analysis of microarray datasets
por: Albogami, Sarah M., et al.
Publicado: (2021) -
Evaluation of the effective dose of amygdalin for the improvement of antioxidant gene expression and suppression of oxidative damage in mice
por: Albogami, Sarah, et al.
Publicado: (2020) -
Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions
por: Alnefaie, Alaa, et al.
Publicado: (2022) -
Effects of combination of obesity, diabetes, and hypoxia on inflammatory regulating genes and cytokines in rat pancreatic tissues and serum
por: Albogami, Sarah, et al.
Publicado: (2022) -
The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives
por: Boechat, J.L., et al.
Publicado: (2021)